文献速递泌尿生殖与妇科肿瘤放疗

局部晚期前列腺癌术后全盆腔放疗对比前列腺床放疗的回顾性分析

Postoperative elective pelvic nodal irradiation compared to prostate bed irradiation in locally advanced prostate cancer - a retrospective analysis of dose-escalated patients.
PubMed 文献 · Radiat Oncol · 2019-06-07

本研究回顾性分析2009至2017年间局部晚期淋巴结阴性前列腺癌根治术后接受剂量递增前列腺床放疗(PBRT)的患者,比较联合或不联合全盆腔放疗(WPRT)对生化无进展生存(bPFS)的影响。结果显示WPRT与更好的bPFS显著相关(多因素HR=0.484,p=0.015),亚组分析中该获益仅见于PSA升高且多数切缘阴性的患者。

要点

  • 剂量递增PBRT基础上加WPRT与局部晚期前列腺癌术后bPFS延长显著相关。
  • 多因素分析显示WPRT的HR=0.484(p=0.015),单因素p=0.032。
  • 亚组中WPRT获益仅见于PSA升高者(p=0.029),切缘阳性非挽救性术后放疗者未见获益。

核心结论

  • 在局部晚期前列腺癌根治术后接受剂量递增放疗的患者中,WPRT相比单纯PBRT观察到更长的bPFS。

研究设计与样本

  • 回顾性分析2009至2017年间局部晚期、淋巴结阴性前列腺癌根治术后接受PBRT±WPRT的患者。
  • 共纳入43例PBRT/WPRT和77例单纯PBRT患者。
  • 切缘阳性(或可检测)者前列腺床EQD-2为79.29 Gy,切缘阴性/不可检测者为71.43 Gy。
  • WPRT剂量为44 Gy,提供给淋巴结转移风险增高的患者。

主要发现

  • WPRT组手术-放疗间隔更短且切除淋巴结数更少。
  • 单因素分析中WPRT与更好的bPFS显著相关(p=0.032)。
  • 多因素分析中WPRT与更好的bPFS显著相关(HR=0.484,p=0.015)。
  • 亚组分析显示PSA升高患者中WPRT获益(p=0.029),该亚组多数(74.1%)切缘阴性。
  • 在几乎全部(96.8%)切缘阳性的非挽救性术后放疗亚组中,WPRT与bPFS延长无关。

临床怎么用

  • 对于局部晚期前列腺癌根治术后剂量递增放疗的患者,可考虑联合WPRT以改善bPFS。
  • WPRT的bPFS获益在PSA升高(挽救性)且切缘多阴性的患者中更明显。
  • 切缘阳性接受非挽救性术后放疗者未观察到WPRT的bPFS获益,决策需个体化。

局限性

  • 本研究为回顾性分析,存在基线不平衡(WPRT组手术-放疗间隔更短、切除淋巴结更少)。
  • 样本量较小(WPRT组43例,单纯PBRT组77例),亚组分析结果需谨慎解读。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: It is uncertain if whole-pelvic irradiation (WPRT) in addition to dose-escalated prostate bed irradiation (PBRT) improves biochemical progression-free survival (bPFS) after prostatectomy for locally advanced tumors. This study was initiated to analyze if WPRT is associated with bPFS in a patient cohort with dose-escalated (> 70 Gy) PBRT. METHODS: Patients with locally advanced, node-negative prostate carcinoma who had PBRT with or without WPRT after prostatectomy between 2009 and 2017 were retrospectively analyzed. A simultaneous integrated boost with equivalent-doses-in-2-Gy-fractions (EQD-2) of 79.29 Gy or 71.43 Gy to the prostate bed was applied in patients with margin-positive (or detectable) and margin-negative/undetectable tumors, respectively. WPRT (44 Gy) was offered to patients at an increased risk of lymph node metastases. RESULTS: Forty-three patients with PBRT/WPRT and 77 with PBRT-only were identified. Baseline imbalances included shorter surgery-radiotherapy intervals (S-RT-Intervals) and fewer resected lymph nodes in the WPRT group. WPRT was significantly associated with better bPFS in univariate (p = 0.032) and multivariate models (HR = 0.484, p = 0.015). Subgroup analysis indicated a benefit of WPRT (p = 0.029) in patients treated with rising PSA values who mostly had negative margins (74.1%); WPRT was not associated with a longer bPFS in the postoperative setting with almost exclusively positive margins (96.8%). CONCLUSION: We observed a longer bPFS after WPRT compared to PBRT in patients with locally advanced prostate carcinoma who underwent dose-escalated radiotherapy. In subset analyses, the association was only observed in patients with rising PSA values but not in patients with non-salvage postoperative radiotherapy for positive margins.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Link C, Honeck P, Makabe A, et al. Postoperative elective pelvic nodal irradiation compared to prostate bed irradiation in locally advanced prostate cancer - a retrospective analysis of dose-escalated patients. Radiat Oncol. 2019. PMID: 31174555. doi:10.1186/s13014-019-1301-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。